| IgA transcytosis and antigen recognition govern ovarian cancer immunity S Biswas, G Mandal, KK Payne, CM Anadon, CD Gatenbee, RA Chaurio, ... Nature 591 (7850), 464-470, 2021 | 148 | 2021 |
| BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells KK Payne, JA Mine, S Biswas, RA Chaurio, A Perales-Puchalt, ... Science 369 (6506), 942-949, 2020 | 111 | 2020 |
| TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures RA Chaurio, CM Anadon, TL Costich, KK Payne, S Biswas, CM Harro, ... Immunity 55 (1), 115-128. e9, 2022 | 95 | 2022 |
| Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells CM Anadon, X Yu, K Hänggi, S Biswas, RA Chaurio, A Martin, KK Payne, ... Cancer Cell 40 (5), 545-557. e13, 2022 | 87 | 2022 |
| IgA-dominated humoral immune responses govern patients' outcome in endometrial cancer G Mandal, S Biswas, CM Anadon, X Yu, CD Gatenbee, S Prabhakaran, ... Cancer research 82 (5), 859-871, 2022 | 39 | 2022 |
| Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation VC Fernandes, VA Golubeva, G Di Pietro, C Shields, K Amankwah, ... Journal of Biological Chemistry 294 (15), 5980-5992, 2019 | 38 | 2019 |
| Genomic and single-cell landscape reveals novel drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma X Song, S Chang, L Seminario-Vidal, A de Mingo Pulido, L Tordesillas, ... Cancer discovery 12 (5), 1294-1313, 2022 | 22 | 2022 |
| Olfactory receptor OR2H1 is an effective target for CAR T cells in human epithelial tumors AL Martin, CM Anadon, S Biswas, JA Mine, KF Handley, KK Payne, ... Molecular cancer therapeutics 21 (7), 1184-1194, 2022 | 20 | 2022 |
| Global regulator of virulence A (GrvA) coordinates expression of discrete pathogenic mechanisms in enterohemorrhagic Escherichia coli through interactions with GadW-GadE JK Morgan, RK Carroll, CM Harro, KW Vendura, LN Shaw, JT Riordan Journal of Bacteriology 198 (3), 394-409, 2016 | 15 | 2016 |
| Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers S Biswas, G Mandal, CM Anadon, RA Chaurio, LU Lopez-Bailon, ... Immunity 56 (11), 2570-2583. e6, 2023 | 13 | 2023 |
| Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in mice CM Harro, J Perez-Sanz, TL Costich, KK Payne, CM Anadon, RA Chaurio, ... The Journal of Clinical Investigation 131 (3), 2021 | 10 | 2021 |
| Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23. 2 locus G Mendoza-Fandiño, PCM Lyra Jr, TC Nepomuceno, CM Harro, ... European Journal of Human Genetics 30 (4), 465-473, 2022 | 7 | 2022 |
| Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center Y Zhang, L Seminario-Vidal, C Varnadoe, Y Lu, N Dong, C Salamanca, ... Leukemia & lymphoma 63 (1), 109-116, 2022 | 7 | 2022 |
| Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma KF Handley, S Mehta, AL Martin, S Biswas, K Maharaj, MZ Nagy, JA Mine, ... Gynecologic oncology 173, 114-121, 2023 | 4 | 2023 |
| Dissecting genetic risk factors in breast cancer CM Harro, ANA Monteiro Oncotarget 8 (8), 12540, 2017 | 3 | 2017 |
| Sézary syndrome originates from heavily mutated hematopoietic progenitors CM Harro, KB Sprenger, RA Chaurio, JJ Powers, P Innamarato, ... Blood Advances 7 (18), 5586-5602, 2023 | 2 | 2023 |
| Olfactory receptor OR5V1 is an effective target for CAR T cells in ovarian cancer (207) A Martin, CMA Galindo, S Biswas, J Mine, G Mandal, P Innamarato, ... Gynecologic Oncology 166, S116, 2022 | 1 | 2022 |
| CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors S Biswas, A Martin, CMA Galindo, J Mine, KK Payne, G Mandal, ... The Journal of Immunology 208 (1_Supplement), 117.16-117.16, 2022 | 1 | 2022 |
| Olfactory receptor OR5V1 is an effective target for second generation and novel NKG2D-based CAR T cells in epithelial gynecologic tumors (184) A Martin, M Nagy, CMA Galindo, S Biswas, J Mine, G Mandal, R Chaurio, ... Gynecologic Oncology 176, S73-S74, 2023 | | 2023 |
| Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma (1286) K Handley, S Mehta, A Martin, S Biswas, K Maharaj, M Nagy, J Mine, ... Gynecologic Oncology 176, S178-S179, 2023 | | 2023 |
Carmen M Anadón GalindoResearch Scientist I, Duke School of Medicine在 duke.edu 的电子邮件经过验证
